| Bloodstream infections caused by Klebsiella pneumoniae in onco‐hematological patients: clinical impact of carbapenem resistance in a multicentre prospective … EM Trecarichi, L Pagano, B Martino, A Candoni, R Di Blasi, G Nadali, ... American journal of hematology 91 (11), 1076-1081, 2016 | 150 | 2016 |
| Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia E Tiacci, L De Carolis, E Simonetti, M Capponi, A Ambrosetti, E Lucia, ... New England Journal of Medicine 384 (19), 1810-1823, 2021 | 108 | 2021 |
| Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) M Caira, A Candoni, L Verga, A Busca, M Delia, A Nosari, C Caramatti, ... haematologica 100 (2), 284, 2015 | 105 | 2015 |
| Current status and future perspectives in targeted therapy of NPM1-mutated AML R Ranieri, G Pianigiani, S Sciabolacci, VM Perriello, A Marra, V Cardinali, ... Leukemia 36 (10), 2351-2367, 2022 | 74 | 2022 |
| Targeting CD33 in chemoresistant AML patient-derived xenografts by CAR-CIK cells modified with an improved SB transposon system MC Rotiroti, C Buracchi, S Arcangeli, S Galimberti, MG Valsecchi, ... Molecular Therapy 28 (9), 1974-1986, 2020 | 50 | 2020 |
| Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML MP Martelli, R Rossi, A Venanzi, M Meggendorfer, VM Perriello, G Martino, ... Blood, The Journal of the American Society of Hematology 138 (25), 2696-2701, 2021 | 45 | 2021 |
| Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial E Tiacci, L De Carolis, E Simonetti, M Merluzzi, A Bennati, VM Perriello, ... Leukemia 35 (11), 3314-3318, 2021 | 43 | 2021 |
| Overlapping features of therapy-related and de novo NPM1-mutated AML J Othman, M Meggendorfer, E Tiacci, C Thiede, R Schlenk, R Dillon, ... Blood 141 (15), 1846-1857, 2023 | 37 | 2023 |
| Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden M Biondi, S Tettamanti, S Galimberti, B Cerina, C Tomasoni, R Piazza, ... Blood, The Journal of the American Society of Hematology 141 (21), 2587-2598, 2023 | 34 | 2023 |
| Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM‐D registry L Pagano, M Stamouli, M Tumbarello, L Verga, A Candoni, C Cattaneo, ... British Journal of Haematology 170 (3), 434-439, 2015 | 34* | 2015 |
| CD123 Is Consistently Expressed on NPM1-Mutated AML Cells VM Perriello, I Gionfriddo, R Rossi, F Milano, F Mezzasoma, A Marra, ... Cancers 13 (3), 496, 2021 | 28 | 2021 |
| IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML VM Perriello, MC Rotiroti, I Pisani, S Galimberti, G Alberti, G Pianigiani, ... Blood Advances 7 (12), 2855-2871, 2023 | 21 | 2023 |
| Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL) R Di Blasi, C Cattaneo, RE Lewis, M Tumbarello, L Angelici, G Dragonetti, ... Annals of hematology 97, 791-798, 2018 | 21 | 2018 |
| Acute myeloid leukemia targeting by chimeric antigen receptor T cells: bridging the gap from preclinical modeling to human studies MC Rotiroti, S Arcangeli, M Casucci, V Perriello, A Bondanza, A Biondi, ... Human gene therapy 28 (3), 231-241, 2017 | 21 | 2017 |
| Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry R Della Pepa, M Picardi, F Sora, M Stamouli, A Busca, A Candoni, ... Supportive care in cancer 24, 3839-3845, 2016 | 18 | 2016 |
| Haematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS) registry—Sorveglianza Epidemiologica Infezioni Funginein Emopatie Maligne (SEIFEM) group … EM Trecarichi, L Pagano, B Martino, A Candoni, R Di Blasi, G Nadali, ... Am J Hematol 91 (11), 1076-81, 2016 | 17 | 2016 |
| Busca A, Aversa F, Fanci R, Melillo L, Lessi F, Del Principe MI, Cattaneo C, Tumbarello M, Haematologic Malignancies Associated Bloodstream Infections Surveillance (HEMABIS … EM Trecarichi, L Pagano, B Martino, A Candoni, R Di Blasi, G Nadali, ... Am J Hematol 91 (11), 1076-1081, 0 | 9 | |
| How I treat refractory/relapsed diffuse large B‐cell lymphomas with CD19‐directed chimeric antigen receptor T cells A Nagler, VM Perriello, L Falini, B Falini British Journal of Haematology 201 (3), 396-410, 2023 | 8 | 2023 |
| CD123 and CD33 co-targeting by balanced signaling on CAR-CIK cells reduces potential off-target toxicity while preserving the anti-leukemic activity of acute myeloid leukemia VM Perriello, MC Rotiroti, I Pisani, G Alberti, G Pianigiani, R Rossi, ... Blood 138, 1699, 2021 | 8 | 2021 |
| Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration? C Girmenia, L Annino, B Mariotti, R Fanci, C Minotti, A Spadea, A Carotti, ... Sabouraudia 54 (5), 445-458, 2016 | 8 | 2016 |
